Search Results - "Garcia‐Horton, Alejandro"

Patient age and donor HLA matching can stratify allogeneic hematopoietic cell transplantation patients into prognostic groups by Garcia‐Horton, Alejandro, Cyriac, Sunu L., Gedde‐Dahl, Tobias, Floisand, Yngvar, Remberger, Mats, Mattsson, Jonas, Michelis, Fotios V.

“…Background Mixed results surround the accuracy of commonly used prognostic risk scores to predict overall survival (OS) and non‐relapse mortality (NRM) in…”
Get full text

An interesting case of thrombocytopenia in pregnancy by Garcia-Horton, Alejandro, Chin-Yee, Ian, Lam, Selay

Get full text

Influenza in patients with hematological malignancies: Experience at two comprehensive cancer centers by Vilar‐Compte, Diana, Shah, Dimpy P., Vanichanan, Jakapat, Cornejo‐Juarez, Patricia, Garcia‐Horton, Alejandro, Volkow, Patricia, Chemaly, Roy F.

“…The burden of influenza infections in patients with hematological malignancies (HMs) is not well defined. We describe the clinical presentation and associated…”
Get full text

Abstracts of the Cell Therapy Transplant Canada 2023 Annual Conference by Maier, Stephanie A, Ahmad, Imran, Berg, Tobias, Berrigan, Susan, Elsawy, Mahmoud, Garcia-Horton, Alejandro, Lam, Wilson, Lapworth, Alix, Melo Garcia, Luciana, Shah, Ravi M, Vasudevan Nampoothiri, Ram, Delisle, Jean-Sébastien

“…On behalf of Cell Therapy Transplant Canada (CTTC), we are pleased to present the Abstracts of the CTTC 2023 Annual Conference. The conference was held…”
Get full text

Hospital-acquired infections at an oncological intensive care cancer unit: differences between solid and hematological cancer patients by Cornejo-Juárez, Patricia, Vilar-Compte, Diana, García-Horton, Alejandro, López-Velázquez, Marco, Ñamendys-Silva, Silvio, Volkow-Fernández, Patricia

“…Cancer patients have a higher risk of severe sepsis in comparison with non-cancer patients, with an increased risk for hospital-acquired infections (HAI),…”
Get full text

Abstracts of the Cell Therapy Transplant Canada 2022 Annual Conference by Maier, Stephanie A, Berg, Tobias, Berrigan, Susan, Bramson, Jonathan, Bredeson, Chris, Cantin, Guy, Daly, Andrew, Davies, Gwynivere A, Elsawy, Mahmoud, Garcia-Horton, Alejandro, Lam, Wilson, Lapworth, Alix, Lepic, Kylie, Melo Garcia, Luciana, Schultz, Kirk R, Vasudevan Nampoothiri, Ram, White, Darrell, Delisle, Jean-Sébastien

“…On behalf of Cell Therapy Transplant Canada (CTTC), we are pleased to present the Abstracts of the CTTC 2022 Annual Conference. The conference was held…”
Get full text

Quizartinib for the treatment of acute myeloid leukemia by Garcia-Horton, Alejandro, Yee, Karen Wl

“… Up to 30% of patients with acute myeloid leukemia (AML) have a mutation in the FLT3 receptor. Molecular targets have acquired a significant interest in the…”
Get more information

Disparities in the Enrollment of Racialized, Ethnic Minority, and Older Adults in Randomized Trials of Acute Myeloid Leukemia: A Systematic Review by Loeb, Nathalie Arielle, Katsnelson, Olivia, Jain, Anshika, Tahvildar, Parsa, Teitelbaum, Daniel, Garcia-Horton, Alejandro

“…Introduction: There are significant racial and ethnic disparities in incidence and survival for patients diagnosed with hematologic malignancies. Understanding…”
Get full text

Anabolic Steroids in Myelodysplastic Syndromes: A Systematic Review by Garcia-Horton, Alejandro, Valliere, Yashoda, Lazo-Langner, Alejandro

“…Background Anabolic steroids, such as danazol, have been used for years in the treatment of myelodysplastic syndromes (MDS). Their successful use has been…”
Get full text

Ureaplasma-Induced Hyperammonemia Syndrome - an Acute Complication Post Allogeneic Stem Cell Transplant by Badami, Rohail, Lepic, Kylie L., Khalaf, Dina, Garcia-Horton, Alejandro, Berg, Tobias, Leber, Brian, Walker, Irwin, Radford, Michael

“…Hyperammonemia syndrome is characterized by elevated serum ammonia levels and neurological dysfunction due to cerebral encephalopathy, andcauses lethargy,…”
Get full text

Anabolic steroids in myelodysplastic syndromes: A systematic review by Garcia-Horton, Alejandro, Valliere, Yashoda, Lazo-Langner, Alejandro

“…•Anabolic steroids such as danazol are widely used in the treatment of MDS.•We conducted a systematic review to assess the evidence for their use.•Study design…”
Get full text

Retinal vein thrombosis: The Internist's role in the etiologic and therapeutic management by Garcia-Horton, Alejandro, Al-Ani, Fatimah, Lazo-Langner, Alejandro

“…Retinal vein occlusion is a common and important cause of vision loss. In general, knowledge about this condition is scant within an internist's practice but…”
Get full text

A Retrospective Cohort Study of Donor Cell Leukemia by Salter, Brittany, Raslan, Omar, Demczuk, Suzanne, Leber, Brian, Garcia-Horton, Alejandro, Walker, Irwin, Berg, Tobias, Butcher, Darci, Lepic, Kylie L., McCready, Elizabeth, Wasi, Parveen, Khalaf, Dina

Get full text

Risk of hepatitis B virus reactivation in HBsAg-negative, anti-HBc-positive patients with myeloproliferative neoplasms treated with ruxolitinib by Garcia-Horton, Alejandro, Smith, Elliot, Maze, Dawn, McNamara, Caroline, Sibai, Hassan, Gupta, Vikas

Get full text

LSD1 Inhibition Enhances Antigen Presentation and Co-Stimulation in AML to Promote T Cell-Mediated Anti-Leukemia Immune Responses by Yan, Yu, Singh, Kanwaldeep, Hartung, Emily, Lee, Brendan, Prabagaran, Pradhariny, Khalaf, Dina, Garcia-Horton, Alejandro, Leber, Brian, Walker, Irwin, Lepic, Kylie L., Kleppe, Maria, Rienhoff Jr, Hugh Young Young, Bramson, Jonathan, Berg, Tobias

“…Allogeneic hematopoietic stem cell transplantation (allo-HSCT) can provide a curative treatment option for acute myeloid leukemia (AML). Donor T cells play an…”
Get full text

Analysis of the Impact of Whole Blood and T-Cell Donor Chimerism after Allogeneic Stem Cell Transplant by Radford, Michael, Garcia-Horton, Alejandro, Badami, Rohail, Jin, Elaine, Usmani, Nida Javed, Grafodatskaya, Daria, McCready, Elizabeth, Khalaf, Dina, Walker, Irwin, Leber, Brian, Lepic, Kylie L., Pond, Gregory, Berg, Tobias

“…Background: Allogeneic stem cell transplant (alloSCT) is one of the few currently available therapies to cure acute myeloid leukemia (AML) and myelodysplastic…”
Get full text

Azacitidine and venetoclax for the treatment of accelerated and blast phase myeloproliferative neoplasms and chronic myelomonocytic leukemia: a case series by Garcia-Horton, Alejandro, Maze, Dawn, McNamara, Caroline J., Sibai, Hassan, Gupta, Vikas, Murphy, Tracy

Get full text

LSD1 Inhibition Synergizes with Venetoclax in Acute Myeloid Leukemia By Targeting Cellular Metabolism by Singh, Kanwaldeep, Hartung, Emily, Muhs, Christina, Alshamleh, Islam, Divakaran, Monisha, Dvorkin-Gheva, Anna, Pishyar, Sara, Prabagaran, Pradhariny, Khalaf, Dina, Garcia-Horton, Alejandro, Foley, Stephen Ronan, Leber, Brian, Walker, Irwin, Lepic, Kylie, Schwalbe, Harald, Serve, Hubert, Kleppe, Maria, Rienhoff, Hugh Young, Berg, Tobias

“…Introduction: Acute myeloid leukemia (AML) is a hematological neoplasm with poor clinical outcomes. The introduction of the BCL2 inhibitor venetoclax in…”
Get full text

Bloodstream infection caused by S. aureus in patients with cancer: a 10-year longitudinal single-center study by Bello-Chavolla, Omar Yaxmehen, Bahena-Lopez, Jessica Paola, Garciadiego-Fosass, Pamela, Volkow, Patricia, Garcia-Horton, Alejandro, Velazquez-Acosta, Consuelo, Vilar-Compte, Diana

“…Background Staphylococcus aureus bloodstream infections (SABIs) represent a significant cause of morbidity and mortality in cancer patients. In this study, we…”
Get full text

Safe Start of Ibrutinib in Patients with Chronic Lymphocytic Leukemia and Uncontrolled Autoimmune Hemolytic Anemia by Garcia-Horton, Alejandro, St. Bernard, Rosanne, Lazo-Langner, Alejandro, Xenocostas, Anargyros, Mangel, Joy, Howson-Jan, Kang, Lam, Selay, Hsia, Cyrus C.

“…It is estimated that 4-10% of patients with chronic lymphocytic leukemia (CLL) will develop autoimmune hemolytic anemia (AIHA) over the course of their…”
Get full text